News
FDA Approves First Twice-a-Year HIV Prevention Shot
Made by Gilead Sciences and sold under the name Yeztugo, the drug gives people a new way to stay protected from HIV without needing daily pills or frequent injections, The New York Times reported. “We’re on the precipice of now being able to deliver the greatest prevention option we’ve had in 44 years of this epidemic,
One of the most effective vaccines available was going to become more accessible—until RFK Jr. dismissed the CDC’s advisory ...
For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.
The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...
The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a ...
A newly posted agenda for next week’s meeting of the just-appointed group of outside vaccine advisers to the US Centers for ...
Vinay Prasad, the FDA’s freshly appointed head of vaccines, has been named chief medical and scientific officer, taking on ...
The Tdap vaccine provides essential protection against tetanus, diphtheria, and pertussis, playing a critical role in ...
The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include ...
A new Lyme disease vaccine, VLA15, is currently being tested and the manufacturers could ask the FDA for authorization as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback